Raymond James Financial Services Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$651K Sell
8,150
-912
-10% -$68.5K ﹤0.01% 2432
2024
Q2
$649K Buy
9,062
+105
+1% +$7.73K ﹤0.01% 2364
2024
Q1
$630K Buy
8,957
+4,961
+124% +$355K ﹤0.01% 2351
2023
Q4
$308K Sell
3,996
-358
-8% -$23.6K ﹤0.01% 2721
2023
Q3
$296K Sell
4,354
-64
-1% -$5.06K ﹤0.01% 2665
2023
Q2
$361K Buy
4,418
+45
+1% +$3.62K ﹤0.01% 2547
2023
Q1
$324K Buy
4,373
+286
+7% +$22K ﹤0.01% 2604
2022
Q4
$339K Buy
4,087
+123
+3% +$9.77K ﹤0.01% 2509
2022
Q3
$281K Buy
3,964
+116
+3% +$10K ﹤0.01% 2611
2022
Q2
$333K Buy
3,848
+552
+17% +$51.7K ﹤0.01% 2521
2022
Q1
$357K Sell
3,296
-372
-10% -$38.4K ﹤0.01% 2588
2021
Q4
$474K Sell
3,668
-8,584
-70% -$1.05M ﹤0.01% 2404
2021
Q3
$1.48M Buy
12,252
+6,756
+123% +$822K ﹤0.01% 1674
2021
Q2
$619K Buy
5,496
+492
+10% +$51.8K ﹤0.01% 2245
2021
Q1
$478K Buy
5,004
+612
+14% +$55.8K ﹤0.01% 2319
2020
Q4
$349K Sell
4,392
-14,968
-77% -$1.08M ﹤0.01% 2369
2020
Q3
$1.2M Buy
19,360
+10,248
+112% +$667K ﹤0.01% 1439
2020
Q2
$602K Buy
+9,112
New +$546K ﹤0.01% 1795
2020
Q1
Sell
-4,280
Closed -$235K 2820
2019
Q4
$235K Sell
4,280
-448
-9% -$23.5K ﹤0.01% 2477
2019
Q3
$231K Buy
+4,728
New +$237K ﹤0.01% 2398

Other funds holding TECH

Raymond James Financial Services Advisors's TECH Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Bio-Techne (TECH) stake by 10% in Q3 2024, selling an estimated $68.5K and leaving 8,150 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #2432.

Raymond James Financial Services Advisors first reported a position in TECH in Q3 2019 and has held it in 20 quarters since. The position peaked at $1.48M in Q3 2021. 562 funds tracked by Wall St. Rank hold TECH as of Q3 2024.

  • Raymond James Financial Services Advisors held 8,150 shares of Bio-Techne worth $651K as of Q3 2024.
  • Raymond James Financial Services Advisors sold 912 Bio-Techne shares in Q3 2024, an estimated $68.5K.
  • Bio-Techne made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2432 holding.
  • Raymond James Financial Services Advisors first reported a position in Bio-Techne in Q3 2019 and has held it in 20 quarters since.
  • Raymond James Financial Services Advisors's Bio-Techne position peaked at $1.48M in Q3 2021.
  • 562 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.